Researchers compared the shared genetic risk and biological foundations of neurological and mental illnesses.
Sanofi, Regeneron prep another FDA submission for Dupixent, this time for a rare skin condition
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS